drugset
Drugs / Endometrial Regenerative Cells
last change Jul 2013 re-read 3 minutes ago

Endometrial Regenerative Cells

also known as ERC

Cell therapy

Developed for
peripheral ischemia
Investigated by
Medistem Inc.

Trials 1

today NCT01558908 · Ph 1/2
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01558908 May 2012 → May 2013 peripheral ischemia Medistem Inc. Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Endometrial Regenerative Cells “intramuscularly derived menstrual mesenchymal stem cells (otherwise known as Endometrial Regenerative Cells, or ERC)” NCT01558908 ↗
Known as ERC “intramuscularly derived menstrual mesenchymal stem cells (otherwise known as Endometrial Regenerative Cells, or ERC)” NCT01558908 ↗
Modality Cell therapy “menstrual mesenchymal stem cells (otherwise known as Endometrial Regenerative Cells, or ERC)” NCT01558908 ↗
Route Intramuscular “Patients will be treated with either 25 million, 50 million, or 100 million ERC by intramuscular injection.” NCT01558908 ↗